Clinical study on Qinghua Liangxue Huayu Decoction combined with Shuigutie in the treatment of chronic liver failure complicated with ascites heat toxin and blood stasis syndrome
- Conditions
- Chronic liver failure
- Registration Number
- ITMCTR2000003865
- Lead Sponsor
- Shanghai Municipal Hospital of TCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Those who meet the diagnostic criteria of chronic liver failure and TCM syndrome differentiation criteria for heat toxin and blood stasis syndrome;
(2) The age from 16 to 80 years old;
(3) Volunteer to participate and sign informed consent.
(1) Acute liver failure, subacute liver failure, chronic and acute (subacute) liver failure;
(2) Patients who have received liver transplantation;
(3) Late stage patients were accompanied with fatal complications, such as hydrocephalus, severe infection (including septic shock, deep fungal infection, infection of more than two sites, double infection, etc.), type I hepatorenal syndrome (rapid renal failure, oliguria within a few days to 2 weeks, muscle liver > 221 µ mol / L), gastrointestinal bleeding, etc;
(4) Patients with liver cancer or other malignant tumors;
(5) Patients with other serious systemic diseases;
(6) Anti HIV positive patients;
(7) Pregnant or lactating women;
(8) Patients with drug or alcohol addiction;
(9) Mental patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adverse event;case fatality rate;
- Secondary Outcome Measures
Name Time Method Coagulation function;Improvement of clinical symptoms of traditional Chinese Medicine;liver function;